PHARMACOGENETIC BASES OF INDIVIDUAL SENSITIVITY AND PERSONALIZED ADMINISTRATION OF ANTIPLATELET THERAPY IN DIFFERENT ETHNIC GROUPS
Cardiovascular diseases (CVDs) are the leading cause of disability and mortality worldwide. Increased thrombosis is the trigger point for the development of various CVDs and their complications, and therefore, therapy with P2Y12-receptor inhibitors is always pathogenetically justified and vital. How...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University
2021-05-01
|
Series: | Farmaciâ i Farmakologiâ (Pâtigorsk) |
Subjects: | |
Online Access: | https://www.pharmpharm.ru/jour/article/view/768 |